Destination Maternity Corporation
(
DEST
) has been making news lately. It recently opened its first Indian
freestanding store and announced a partnership with entertainer
Jessica Simpson on a new maternity line. This Zacks #1 Rank (Strong
Buy) is still a value stock with a forward P/E of 12.6.
Most people know Destination Maternity through its biggest brands
of Motherhood Maternity and a Pea in the Pod.
It operates 643 stores in the United States and Canada under those
two names as well as Destination Maternity. The company also
operates in 1384 leased department locations and has a website
through destinationmaternity.com.
The company also sells its Oh Baby by Motherhood collection through
a licensed arrangement at 1,100 Kohls and on kohls.com.
Internationally, it has 94 international franchised locations,
including 80 shop-in-shop locations and 14 Destination Maternity
brand stores.
First Freestanding Store in India
On May 16, the company announced the opening of its first
freestanding store in Ambience Mall, the largest mall in India,
which is located in Gurgaon which is near Delhi.
It is partnering with Mahindra Retail, which since 2009 had already
been licensing the company's brands in shop-in-shops within its own
Mom & Me stores.
Jessica Simpson Maternity Line To Launch
On May 14, Destination Maternity announced that it had entered into
an exclusive licensing agreement between Camuto Group, the master
licensee of the Jessica Simpson Collection, for a full line of
maternity apparel.
"I'm so excited to partner with Destination Maternity to design a
collection of fashionable styles that make you look and feel
great!" Simpson has said, "You want to wear clothes that are
flattering to your baby bump; you want to show your bump off."
The line will have a 70s vintage feel. It is due to launch in the
fall.
Destination Maternity Beat By 15% in Fiscal Q2
On Apr 26, Destination Maternity reported fiscal second quarter
2012 results and surprised on the Zacks Consensus by 5 cents.
Earnings per share were 38 cents compared to the consensus of 33
cents.
This was higher than the company's January guidance of between 21
and 31 cents per share.
Sales rose 3% to $137.8 million from $133.8 million in last year's
quarter. The increase was primarily due to an increase in
comparable sales and increased sales due to the expansion of its
leased department relationship with Macy's.
Comparable sales rose 3.2% compared to just 0.3% in the year ago
quarter. Comparable sales includes Internet sales. It included an
extra calendar day due to leap year. Adjusting for the differences,
comparable sales rose 0.7%.
Raised Full Year Guidance
With a better than expected second quarter, Destination Maternity
raised its full year guidance to a range of $1.38 to $1.62 from the
prior range of $1.26 to $1.51.
However, that is still 12% below last year's earnings of $1.76.
Zacks Consensus Estimate Rises
Given the more bullish full year guidance, the analysts raised
estimates over the last 90 days. The fiscal 2012 Zacks Consensus
jumped to $1.53 from $1.36 in the last 3 months.
Still Has Value
Shares sold off in 2011 on jitters over the U.S. economy but have
since rebounded.
Still, shares haven't regained 2 year highs.
Destination Maternity still has a lot of value. In addition to a
P/E under 15, which is my cut-off for value, it also has a
price-to-book ratio of 2.7. A P/B ratio under 3.0 can mean a
company is a value.
Its price-to-sales ratio is also indicating value at 0.5. A P/S
ratio under 1.0 usually means a company is undervalued.
Juicy Dividend
On top of the value, shareholders are being rewarded with a juicy
dividend currently yielding 3.6%. The average for its industry is
to pay no dividend whatsoever so this is a nice added bonus.
Destination Maternity is an attractive value stock in the specialty
retail sector.
Tracey Ryniec is the Value Stock Strategist for
Zacks.com
. She is also the Editor of the Turnaround Trader and Insider
Trader services. You can follow her on twitter at
@TraceyRyniec
.
DESTINATION MTR (DEST): Free Stock Analysis
Report
To read this article on Zacks.com click here.